Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
81.49
-0.44 (-0.54%)
At close: Feb 13, 2026, 4:00 PM EST
81.01
-0.48 (-0.59%)
After-hours: Feb 13, 2026, 7:26 PM EST
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $5.09 billion as of February 13, 2026. Its market cap has increased by 118.50% in one year.
Market Cap
5.09B
Enterprise Value
4.43B
1-Year Change
118.50%
Ranking
Category
Stock Price
$81.49
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $5.09B, an increase of 2,870.50%. That is a compound annual growth rate of 42.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.09B | -6.70% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 6.07B |
| Mirum Pharmaceuticals | 5.98B |
| PTC Therapeutics | 5.69B |
| Cogent Biosciences | 5.66B |
| Immunovant | 5.28B |
| Structure Therapeutics | 5.25B |
| Crinetics Pharmaceuticals | 4.88B |
| Celcuity | 4.82B |